Search Within

Paola Ghione

Formats
  1. Meeting Abstract (57)
  2. Journal Article (22)
  3. Editorial (3)
  4. Research Letter (3)
  5. Review (2)
Groups
  1. Sloan Kettering Institute Postdocs (87)
  2. Department of Medicine (76)
  3. Hematologic Malignancies, Division of (76)
  4. Center for Hematologic Malignancies (74)
  5. Lymphoma (73)
  6. Population Sciences Research Program (57)

More Groups

People
  1. Steven Horwitz (57)
  2. Alison Moskowitz (48)
  3. Maria Palomba (43)
  4. Ahmet Dogan (36)
  5. Ariela Noy (35)
  6. Zachary Epstein-Peterson (34)

More People

Years
  1. 2025 (5)
  2. 2024 (28)
  3. 2023 (23)
  4. 2022 (2)
  5. 2021 (6)
  6. 2020 (14)

More Years

Publications
  1. Blood (45)
  2. Hematological Oncology (8)
  3. Journal of Clinical Oncology (6)
  4. Haematologica (5)
  5. Blood Advances (4)
  6. Blood Cancer Journal (2)

More Publications

Publishers
  1. American Society of Hematology (49)
  2. Wiley Blackwell (11)
  3. American Society of Clinical Oncology (6)
  4. Ferrata Storti Foundation (5)
  5. Springer (3)
  6. Taylor & Francis Group (3)

More Publishers

Results (87)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Pembrolizumab for front-line treatment of extranodal NK/T-cell lymphoma
    Meeting Abstract

    Moskowitz, A.; Advani, R. H.; Ganesan, N.; Chang, T.; Hancock, H.; Davey, T.; Miller, T.; Gibaldi, A.; Smith, M.; Assini, A.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Central nervous system bridging radiotherapy (CNS-BRT) achieves rapid cytoreduction prior to car T-cell therapy for aggressive B-cell lymphomas
    Meeting Abstract

    Cederquist, G.; Schefflein, J.; Devlin, S.; Shah, G.; Shouval, R.; Hubbeling, H.; Tringale, K.; Fregonese, B.; Hajj, C.; Boardman, A.; more...
    Neuro-Oncology (2024)

    Fulltext@MSK | Save
  • Central nervous system lymphomas—Assessment and treatment and prevention of central nervous system relapse
    Review

    Ghione, P.; Lewis, K. L.; Bobillo, S.; Nayak, L.; Schorb, E.; Nichelli, L.; Ng, A.; Savage, K. J.; McKay, P.; Nastoupil, L.; more...
    Hematological Oncology (2024)

    Fulltext@MSK | Save
  • Limited stage high grade B-cell lymphoma with MYC, BCL2 and/or BCL6 rearrangements: BCL2 rearrangements drives the poor outcomes
    Research Letter

    Lue, J. K.; Luttwak, E.; Rivas-Delgado, A.; Irawan, H.; Boardman, A.; Caron, P. C.; David, K.; Epstein-Peterson, Z.; Falchi, L.; Ghione, P.; more...
    Blood Cancer Journal (2024)

    Fulltext@MSK | Save
  • CNS bridging radiotherapy achieves rapid cytoreduction before CAR T-cell therapy for aggressive B-cell lymphomas
    Journal Article

    Cederquist, G. Y.; Schefflein, J.; Devlin, S. M.; Shah, G. L.; Shouval, R.; Hubbeling, H.; Tringale, K.; Tomas, A. A.; Fregonese, B.; Hajj, C.; more...
    Blood Advances (2024)

    Fulltext@MSK | Save
  • CHRONOS-4: Phase 3 study of copanlisib plus rituximab-based immunochemotherapy in relapsed indolent B-cell lymphoma
    Journal Article

    Zinzani, P. L.; Wang, H.; Feng, J.; Kim, T. M.; Tao, R.; Zhang, H.; Fogliatto, L.; Artigal, C. M.; Özcan, M.; Yanez, E.; more...
    Blood Advances (2024)

    Fulltext@MSK | Save
  • Spotlight on polatuzumab vedotin: New standards for diffuse large B-cell lymphoma?
    Review

    Ghione, P.; Salles, G.
    Haematologica (2024)

    Fulltext@MSK | Save
  • Emapalumab as salvage therapy for adults with malignancy-associated hemophagocytic lymphohistiocytosis
    Research Letter

    Johnson, W. T.; Epstein-Peterson, Z. D.; Ganesan, N.; Pak, T.; Chang, T.; Dao, P.; Moskowitz, A. J.; Stuver, R. N.; Ghione, P.; Galasso, N.; more...
    Haematologica (2024)

    Fulltext@MSK | Save
  • The CNS relapse in T-cell lymphoma index predicts CNS relapse in patients with T- and NK-cell lymphomas
    Journal Article

    Bhansali, R. S.; Ellin, F.; Relander, T.; Cao, M.; Li, W.; Long, Q.; Ganesan, N.; Stuver, R.; Horwitz, S. M.; Wudhikarn, K.; more...
    Blood Advances (2024)

    Fulltext@MSK | Save
  • A comparison of 3-year follow-up of ZUMA-5 (axicabtagene ciloleucel) with SCHOLAR-5 in relapsed/refractory follicular lymphoma
    Editorial

    Ghione, P.; Palomba, M. L.; Ray, M. D.; Limbrick-Oldfield, E. H.; Owen, J.; Kanters, S.; Bobillo, S.; Ribiero, M. T.; Jacobson, C. A.; Neelapu, S. S.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2024)

    Fulltext@MSK | Save